About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Texas | 1,769 Studies

Clinical Trials Breast CancerTexas

Breast Cancer Clinical Trials in Texas

Find 1,769 clinical trials for breast cancer near Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1701-1720 of 1,769 trials

TerminatedStudy of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene AmplificationsBBI-355 is an oral, potent, selective checkpoint kinase 1 (or CHK1) small molecule inhibitor in development as an ecDNA (extrachromosomal DNA) directed therapy (ecDTx).NCT05827614·Los Angeles, California and 15 others Active not recruitingPre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)This research trial is studying a combination of neoadjuvant radiotherapy (RT), immunotherapy (pembrolizumab) and chemotherapy for lymph node-positive, triple negative (TN) or…NCT04443348·Washington D.C., District of Columbia and 9 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownWhole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical CancerRATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above body temperature.NCT00003135·Houston, Texas

CompletedA Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast CancerThis study was a Phase III, randomized, double-blind, placebo-controlled, multicenter international clinical trial conducted to investigate the use of pertuzumab in combination…NCT00567190·Scottsdale, Arizona and 321 others

RecruitingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryInternational registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool…NCT03452774·Birmingham, Alabama and 67 others

Active not recruitingEvaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)The goal of this clinical research study is to find out if stereotactic spine radiotherapy is safe and effective in the treatment of metastatic spine tumors.NCT00508443·Houston, Texas

CompletedBEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerThe main objective of the trial is to compare Invasive Disease-Free Survival (IDFS) of patients randomised to treatment with adjuvant chemotherapy alone or to adjuvant…NCT00528567·Huntsville, Alabama and 402 others

CompletedA Retrospective Breast Reconstruction StudyTo collect data on patients who have previously undergone breast reconstruction utilizing SimpliDerm and other HADMs.NCT04060134·Montgomery, Alabama and 4 others

Active not recruitingRoll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibThe rationale of the ROSY-O study is to continue to provide study treatment for patients who have participated in a parent study with olaparib and who are continuing to derive…NCT04421963·Boca Raton, Florida and 106 others

TerminatedStudy of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid TumorsPhase I, first-in-human, open-label, multicenter, dose-escalation and dose expansion study with the aim of exploring safety, tolerability and preliminary antitumor activity of…NCT04182516·Houston, Texas and 9 others

RecruitingA Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid TumorsThis study is a Phase 1/2, first-in-human, open-label, clinical trial to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of HMBD-501 in patients with…NCT06956690·La Jolla, California and 6 others

CompletedTaxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer PatientsThe purpose of this study is to learn if the biomarker information obtained (learned or received) from the earlier studies can tell us whether or not Taxotere and/or…NCT00206518·Houston, Texas

CompletedThe Change Cycle Intervention for Improving Quality of Life in Breast Cancer SurvivorsThis study is proposed to assess long-term Quality of Life issues in breast cancer survivors by measuring the impact on the quality of life made by the structured "Change Cycle…NCT01734499·Amarillo, Texas

RecruitingThe C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense BreastsTo learn whether a new imaging technology, Contrast-Enhanced Mammography (CEM), compared to standard mammography, can better detect breast cancers in women with dense breastsNCT05667532·Houston, Texas

CompletedBootcamp During Neoadjuvant Chemotherapy for Breast CancerThis is a randomized, single-site pilot study incorporating one control group. This research involves an exercise group and a non-exercise group (control group).NCT01411787·Dallas, Texas

Active not recruitingA Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast CancerThis study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called…NCT03975647·Mobile, Alabama and 489 others

CompletedComparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast CancerThis study is being carried out to see if treatment with ZD1839 (Gefitinib) combined with Arimidex (Anastrozole) has improved efficacy over Arimidex alone in preventing…NCT00077025·La Jolla, California and 26 others

TerminatedA Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast CancerThe main purpose of this study is to measure how well abemaciclib works in participants with early breast cancer who are taking hormone therapy after surgery.NCT04752332·Glendale, Arizona and 114 others

TerminatedNeratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis TestThis study is to learn if the combination therapy of capmatinib and neritinib can help to control metastatic or locally advanced breast cancer.NCT05243641·Houston, Texas

CompletedStudy to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCThe purpose of this study is to collect additional safety and efficacy data for the combination of ribociclib + letrozole in men and pre/postmenopausal women with HR+HER2-…NCT02941926·Anchorage, Alaska and 494 others

PreviousPage 86 of 89Next

Other Conditions in Texas

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma